May 2025 issue of Topics in Antiviral Medicine™ Now Available: Earn Up To 9.0 CME Credits

The May 2025 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/may-2025/. This issue offers up to 9.0 CME credits and includes the 2025 update on the Drug Resistance Mutations in HIV-1 Figure, a review of data from the Ninth Biennial HIV and Liver Disease Conference, and 3 articles showcasing the latest data from the 2025 Conference on Retroviruses and Opportunistic Infections.

Special Contribution

• 2025 Update of the Drug Resistance Mutations in HIV-1
  Annemarie M. Wensing, MD, PhD, Vincent Calvez, MD, PhD, Francesca Ceccherini-Silberstein, PhD, Charlotte Charpentier, PharmD, PhD, Huldrych F. Günthard, MD, Donna M. Jacobsen, BS, Roger Paredes, MD, PhD, Robert W. Shafer, MD, Douglas D. Richman, MD

Review

• HIV and Liver Disease: Optimizing Care and Identifying the GapsKenneth E. Sherman, MD, PhD, Phyllis C. Tien, MD, MSc, David L. Thomas, MD, MPH

Selected Highlights of the 2025 Conference on Retroviruses and Opportunistic Infections

• CROI 2025: Neuropsychiatric Complications in People With HIVMichael J. Corley, PhD, Sarah B. Joseph, PhD, Phillip Chan, PhD, MBChB

• CROI 2025: Tuberculosis, Mpox, and Other Infectious Complications in People With HIVAndrew D. Kerkhoff, MD, PhD, Jason Zucker, MD, Diane V. Havlir, MD

• CROI 2025: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted DiseasesSusan P. Buchbinder, MD, Albert Y. Liu, MD, MPH

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this issue for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.